(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology >  Ethical Pharmaceuticals
 
 Ethical Pharmaceuticals Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  Next »
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing

 

Summary

GBI Research, leading business intelligence provider, has released its latest research report, entitled “Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain management....


 

$3500.00
       
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge”. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical needs into the market place....


 

$3500.00
       
Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Summary

GBI Research, a leading business intelligence provider, has released its latest research, “Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen”, which provides insights into the global contraceptives market and market forecasts until 2018. The report provides an in-depth analysis of the most commonly used contraceptives, such as oral, topical, and injectable contraceptives, and devices such as intrauterine devices, condoms, and vaginal rings....

 

$3500.00
       
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share

Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share”, which provides insights into the global statins market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts....

 

$3500.00
       
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

Summary

GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants” which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region....

 

$3500.00
       
Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff

Summary

GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff”. A highly dynamic market scenario is expected in Neurodegenerative diseases in the next few years, with a number of patent expiries and anticipated new drug approvals....

 

$3500.00
       
The World Market for Pain Management Drugs and Devices

The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other clinicians has expanded....

 

$3500.00
       
Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

GBI Research’s report “Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis into the market. Pain is a widespread problem across the world....

 

$3500.00
       
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth”. Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency of disease relapses....

 

$3500.00
       
Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm andIntensified Competition Expected to Drive Growth by 2019

“Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose....

 

$3500.00
       
The 2012 Market for Antibodies

As players in the rapidly growing antibodies market, companies both large and small are enjoying a consistent source of revenue stream in what appears to be an almost recession-proof line of products. Scientific research is yielding promising diagnostic and therapeutic uses for antibodies in the treatment of cancer, autoimmune diseases and a host of other maladies that demand a healthy share of public and private funds....

 

$3200.00
       
Global Cardiovascular Drugs Market 2012-2016

TechNavio's analysts forecast the Global Cardiovascular Drugs market to decline at a CAGR of 10.47 percent over the period 2012-2016....

 

$3000.00
       
Partnering Deals and Alliances with Big Pharma

The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies.

Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits:

Detailed partnering activity profiles for each of the top 50 big pharma companies
Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners
Partnering therapy focus revealed
Partnering activity since 2007 – number of deals per year
Full listing of partnering deals


 

$2995.00
       
Antibody Partnering Terms and Agreements

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.

 

$2995.00
       
PharmaSphere: Asia Pacific Deal Trends, 2004–2013

"PharmaSphere: Asia Pacific Deal Trends, 2004–2013" offers an in-depth understanding of the key deals that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships....

 

$2995.00
       
Stem Cell Approaches in Neurology and Psychiatry - 25 Trendsetters for 2013

An industry insider report on innovative research and development in stem cell technology for the central nervous system
  • Analyzes the scientific approaches and challenges to utilizing stem cells in the CNS
  • Discusses trends and drivers including funding and regulatory issues
  • Reveals promising treatment indications and pipelines
  • Details cell therapies for Parkinson's, SCI, stroke, Alzheimer's, ALS, MS, retina and more
  • Examines business models leveraging the promise of stem cells
  • Sheds light on investment opportunities and risks
  • Provides in-depth profiles of trendsetters and trailblazers


 

$2950.00
       
Royalty Financing Partnering Terms and Agreements

The Royalty Financing Terms and Agreements report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

Comprehensive directory of royalty financing deals since 2007
Royalty financing contract documents
Royalty financing agreement terms
Royalty financing agreement structure
Top royalty financing deals by value
Most active Royalty financing dealmakers



 

$2795.00
       
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

This report “Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012” published in March 2012 provides a compilation of business, commercial, clinical and scientific information about GLP-1 receptor agonists. A comprehensive analysis of the state of the art and key trends guides the reader through this emerging antidiabetic drug class....

 

$2600.00
       
« Previous     1  2  3  4  5  6  7  8   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X